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Background and Aim. Germline mutations of the adenomatous polyposis coli (APC) gene cause familial adenomatous polyposis
(FAP),anautosomaldominantinheriteddiseasemainlycharacterizedbycolorectaladenomatouspolyposis.GeneticstudiesofFAP
have shown that somatic APC mutations are dependent on the position of the germline APC mutation. However, the molecular
mechanismunderlyingthesegenotype-phenotype associationsforAPCinChineseremainlargelyunknown.PatientsandMethods.
In this study, we investigated the APC gene mutation in a Chinese FAP family by systematic screening with multiplex ligation-
dependent probe ampliﬁcation (MLPA), denaturing high-performance liquid chromatography (dHPLC), and DNA sequencing.
Promoter methylation was detected by methylation-speciﬁc PCR. Results. The identical germline mutation c.1999 C>T (Q667X)
of APC was identiﬁed in 5 aﬀected members, among which 2 members carried somatic mutations of APC, one with promoter
hypermethylation and the other with loss of wild-type allele in their adenomas. The somatic mutations were shown connected
with the disease severity, demonstrating a unique genotype-phenotype association in this FAP pedigree. Conclusion.T h es t u d y
revealed the existence of novel pathogenic mutations in Chinese patients with FAP. Somatic mutations are of particular interest
because of the unusual phenotypic features shown by patients.
1.Introduction
Familial adenomatous polyposis (FAP; MIM #175100) is a
common hereditary syndrome characterized by early onset
form of colorectal cancer based on multiple adenomas in
the colon and rectum [1]. The penetrance of the genetic
defect is approximately 100%. The responsible gene for
FAP, the adenomatous polyposis coli (APC) gene, was
isolated and localized to chromosome 5q21-22 by positional
cloning [2, 3]. More than 900 diﬀerent mutations have
been registered in the Human Gene Mutation Database
(http://www.hgmd.cf.ac.uk/ac/). Most mutations in APC are
nonsense or frameshift mutations that cause premature
truncationoftheAPCprotein,andmorethan60%havebeen
localized within exon 15 [4, 5]. In addition, several studies
revealed that the exon-spanning fragment variations in APC
genemay bea frequent cause of FAP[6,7].Inseveralstudies,
anassociation betweenthelocationoftheAPCmutationand
the phenotype in FAP patients has been described [8]. Iden-
t i ﬁ c a t i o no ft h eA P Cm u t a t i o ni no n ea ﬀected individual of
a family opens the possibility of testing the at-risk members
for the same mutation, thus preventing the development of
colorectal cancer by the prophylactic removal of the bowel.
Although the APC gene has been extensively studied in the
Caucasianpopulation,ithasnotbeenwidelydescribedinthe
Chinese population. The molecular mechanisms underlying
the genotype-phenotype associations forAPC remain largely
unknown [9, 10]. Furthermore, the possible role of APC
inactivation by methylation need to be further assessed. In
this study, we screened the whole coding region of APC
gene by MLPA, dHPLC, and DNA sequencing to identify
the germline and somatic mutations in all of the aﬀected
members of a suspicious FAP family and discussed the
genotype-phenotype association.
2.Patientsand Methods
The FAP family pedigree (Figure 1) consists of 7 members,
with 5 aﬀected and 2 unaﬀected members. The proband2 ISRN Gastroenterology
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Figure 1:Pedigree ofthefamilywithautosomallydominantinheritance offamilialadenomatouscoli.d=died; Age=current age; Blackened
symbols indicate aﬀected individuals. Proband is denoted with a ﬁlled arrowhead, and roman numbers indicate generations.
was a 40-year-old female presenting to our hospital in
August, 2005, with increasing intermittent rectal bleeding
and abdominal pain for several months. Her family history
included her father and two younger sisters, who died of
rectal cancer in the age of 49, colorectal cancer at age
of 38, and endometrial cancer at age of 27, respectively.
Colonoscopy performed in the proband revealed numerous
polyps carpeting the entire colon and rectum. Histolog-
ical examination of biopsied specimens revealed ﬁndings
of poorly diﬀerentiated adenocarcinomas, and the other
polyps were diagnosed as tubular adenomas with mainly
heavy-grade dysplasia. On the basis of these ﬁndings, the
patient was diagnosed to have FAP. With informed consent
from the patient and her family members, we collected
their peripheral blood. For the numbered family members,
colonoscopy examination was performed, and the found
adenomas, adenocarcinomas, and the paired normal tissues
were obtained. Each biopsy was assessed by the analysis
of hematoxylin and eosin-stained sections. Fifteen control
subjects were selected from medical checkup people in our
hospital free from cancer.
DNA was isolated from peripheral blood and obtained
tissue from consenting family members with the Qiamp
DNA Blood and Tissue Extraction kit (Qiagen Corp,
Germany), respectively. MLPA analysis to determine the
large fragment duplication or deletion and allelic loss in
APC gene was performed using the Salsa MLPA kit P043
APC (MRC-Holland Corp, Amsterdam, The Netherlands)
according to the protocol supplied with the kit with a few
modiﬁcations according to the condition in our laboratory.
The WAVE System 3500 (Transgenomic, Inc., Omaha, NE)
and associated WAVE-Maker 4.1 software were used to
analyze the exons 1 to 15 of APC gene, each of them in
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Figure 2: APC exon 15A by denaturing high-performance liquid
chromatography (dHPLC) in the FAP pedigree family. f1 is the
proband; f2 and f7 are the unaﬀected members; f3–f6 are the
aﬀected members.
the range of 200–500bp. Preparation and analysis of the
PCR products was carried out as previously described [11].
In brief, oligonucleotide primers used in PCR for dHPLC
had been reported previously [1, 4, 12]. PCR products from
analyzed samples were denatured and then cooled slowly to
room temperature before dHPLC to maximize heteroduplex
formation. The precisegradients for temperature and buﬀers
giving the optimal TM for each fragment were calculated
by WAVE-Maker 4.1 software (Transgenomic Inc., USA).
The sequence variations could be detected using automated
sequencing of variant fragments observed by dHPLC. Anal-
ysis of DNA sequencing was carried out on the ABI PrismISRN Gastroenterology 3
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Figure 3: Sequence analysis: sequence spanning c.1999 C>To fi n d i v i d u a l3 ,a na ﬀected family member. Arrow indicates a double peak at
the site of the single nucleotide mutation,which leads to Q667X.
3100 Avant Genetic Analyzer (Applied Biosystems, Foster
City, CA).
Methylation-speciﬁc PCR was used for methylation
analysis of the APC promoter. Brieﬂy, 1μgD N Aw a s
treated with sodium bisulﬁte using the CpGenome kit
(Cat#S7820, Chemicon, USA) according to manufacturer’s
instructions. DNA methylation in the CpG islands of
APC was determined by methylation-speciﬁc PCR. Primer
sequences of APC promoter for the unmethylated DNA
were 5
 -GGGCTAGGGCTAGGCAGG-3
  (sense) and 5
 -
GCTGCACCAATACAGCCAC-3
  (antisense)amplifying the
98-bp product, while those for the methylated DNA were 5
 -
GGGTTAGGGTTAGGTAGG-3
  (sense) and 5
 -AACTAC-
ACCAATACAACCAC-3
  (antisense). The PCR reaction was
carriedoutusingahotstartwithadenaturationcycleof94◦C
for 2min and 80◦C for 3min, followed by 30 cycles of 30s
at 95◦C, 30s at 55◦C, 40s at 72◦C, and ﬁnal extension for
5minat72 ◦C. The speciﬁcity of the reactions for methylated
DNA is conﬁrmed using unmethylated human sperm DNA
and CpGenome Universal Methylated DNA.
3.Results
In this study, systematic screening strategy including MLPA,
dHPLC, and sequencing was used to enable optimal muta-
tion detection of germline and somatic mutations of APC
gene in this FAP family.
3.1. Germline Mutations. The whole coding region of APC,
exon by exon, was subsequently screened for mutation by
dHPLC in constitutional DNA from this family. Only one
aberrant peak elution proﬁles in the fragment of exon 15A
from constitutional DNA were shown for each of Number
1, 3, 4, 5, and 6 (Figure 2), which indicates they harbor the
identical germline mutation. Sequence analysis revealed a
c.1999 C>T substitution predicted to cause the substitution
at codon 667 from Glutamine to STOP (Q667X) (Figure 3).
While the 2 unaﬀected family members and 15 normal
individuals as control were homozygous C at the same
position.ByMLPA,largedeletionorduplicationofAPCgene
was not found in constitutional DNA. All members and 15
controls showed consistently normal control peak pattern as
described by the kit’s manufacturer.
3.2. Somatic Mutations. Somatic mutations of APC gene
were screening by dHPLC and MLPA in the collected tissues
from this family. Out of 5 aﬀected members’ tissues, the
adenomas from Number 3 were exclusively found somatic
loss of wild-type APC allele (Figure 4). The APC promoter
methylation was exclusively identiﬁed in both carcinomas
and adenomas from Number 1 and in none of the other
members (Figure 5).
3.3. Clinical Manifestation of the Family Members. Colono-
scopicexamination performed in theaﬀectedmembers(nos.
1, 3, 4, 5, and 6) found that the number of colonic polyps
presented in the colorectum substantially increased along
with their growth older. For Number 1 with additional
APC promoter, hypermethylation has a severe form of FAP
with colon carcinomas and hepatoblastoma, the typical
extracolonic manifestations. For Number 3 with loss of
wild-type allele, the severe phenotype was manifested with
tubular adenomas with mainly heavy-grade dysplasia in
colonand gastric fundal polyps.Nopolypswere found in the
colonoscopy performed in Numbers 2 and 7, corresponding
to their APC-negative mutation.
4.Discussion
Examination of APC germline mutations in FAP families is
being used as an eﬃcient tool for predictive testing of sub-
jects at risk. However, its relevance for clinical management
of individual patients is still open to question.
By dHPLC and sequence analysis, we found an APC
Q667X in constitutional DNA, which was identical in 5
aﬀected members and also presented in their tissues. The
aﬀected members have manifested an aggressive form of
FAP with early onset of colonic adenoma and extracolonic
manifestations, and the unaﬀected members have shown
normal phenotype. We suggest the germline mutation of
Q667X is the cause of clinical phenotype of the family with
FAP.4 ISRN Gastroenterology
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Figure 4: Peak pattern of exons from APC genes in MLPA. The x-axis shows the size of PCR products, and the y-axis reﬂects the relative
quantity of PCR products. The arrows indicate a deletion of promotor region 1-2, exon 1–15 in the APC gene discovered in the adenomas
from Number 3 of the family (a). The amount of PCR products in the APC gene was only half of a normal control (b).
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Figure 5: Methylation of the APC promoter was exclusively
identiﬁed in the adenomasand carcinomasfrom Number 1. Primer
sets for methylation-speciﬁc PCR are designated as methylated (M)
and unmethylated (U) DNA. N (1): normal cancer-free tissue from
Number1.A(1):AdenomafromNumber1.C(1):Carcinomafrom
Number 1. +: Positive control. −: blank control.
Recent studies revealed that 5% of classic FAP was
ascribed to the large deletions in the APC, which cannot
easily be detected by conventional mutation-detection tech-
niques[6,13].Therefore,weusedMLPAtestinourmutation
analysis strategy toscreenfor exon-spanning deletionsin this
family though no large deletion was found in the constitu-
tional DNA from this family. However, Number 3 was found
somatic loss of wild-type APC allele in the adenomas.
The APC protein contains seven 20-amino acid repeats
(20AARs) which are involved in degrading the transcrip-
tional cofactor beta-catenin and hence negatively regulate
Wnt signaling [14, 15]. The germline mutation Q667X
encoded a limited amount of functional APCprotein (23.4%
of normal APC protein) and led to the truncated protein,
which leaves zero 20AARs, implying a potential unfolding of
beta-catenin. Moreover, the somatic loss of wild-type APC
allele, as the “second hit”, was found in the adenomas from
Number 3. Interestingly, the member carrying this somatic
mutation had a more severe form of FAP with extracolonic
manifestation though severe dysplasia may accumulate over
time. We suggested that the somatic mutation may not
only reduce the residual activity of the mutant germline
allele but also inactivate the APC wild-type allele, and thus
probably initiate the tumorigenesis. Several studies [16, 17]
have shown that usually germline mutationsbetween codons
1285 and 1378 were strongly associated with somatic loss of
the wild-type APC allele in colorectal polyps in Caucasian
population, which was inconsistent with our study. We
thought it was the unique somatic APC mutation pattern
that presentsthe clinicalmanifestation in thisChinese family
pedigree.
The multitude of genetic changes may originate with
a single mutation, which evolves towards tumorigenesis in
conjunctionwithothergeneticandepigeneticabnormalities,
in particular CpG island hypermethylation [18]. In this
family, we suggested that the promoter hypermethylation
observed in adenomas and carcinomas from the proband
may inactivate the second allele of APC and manifest the
severe phenotype. These changes sometimes appear to be
accumulated in all of the stages of colorectal tumorigenesis.
In FAP, correlations between site of mutation in the
APC gene and severity of colonic polyposis or extracolonicISRN Gastroenterology 5
manifestations are demonstrated [19–21]. However, several
ﬁndings indicated that the geographic diﬀerences in APC
mutation pattern may manifest population diﬀerences in
t h eF A Pp h e n o t y p e[ 22–24]. Therefore, further studies with
more Chinese family pedigrees analysis are necessary to give
the overall view of the mutation pattern and to evaluate
the genotype-phenotype association in Chinese FAP families
compared to FAP families in other populations.
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